Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
29.00
+1.30 (4.69%)
Sep 16, 2026, 1:20 PM EDT - Market open

Biodesix Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
102.9496.188.580.1776.5674.4671.3265.5660.954.8549.0944.0341.6440.7238.2135.8331.2532.1954.5174.31
Revenue Growth (YoY)
34.46%29.05%24.08%22.29%25.70%35.76%45.30%48.92%46.25%34.70%28.46%22.88%33.24%26.51%-29.89%-51.79%-59.40%-53.57%19.64%177.29%
Cost of Revenue
18.0117.6216.7216.1816.2616.115.5714.6113.6613.0213.0112.9413.3514.0914.1513.3412.4315.5430.5242.68
Gross Profit
84.9378.4871.7863.9960.358.3655.7550.9647.2541.8336.0831.0828.326.6324.0622.4918.8216.6523.9931.63
Selling, General & Admin
93.2391.3687.5584.7983.0980.3480.4576.4871.9668.9567.3967.7667.3865.9661.4658.3956.8953.0850.5249.02
Research & Development
12.2812.421211.5511.110.399.569.038.438.789.9911.6612.713.1513.112.3912.7112.6712.7913.04
Operating Expenses
105.51103.7799.5596.3494.1990.7390.0185.5280.3977.7377.3879.4380.0879.1174.5670.7869.665.7563.3162.07
Operating Income
-20.58-25.3-27.77-32.35-33.89-32.37-34.26-34.56-33.14-35.9-41.3-48.34-51.78-52.48-50.51-48.3-50.78-49.1-39.32-30.43
Interest Expense
-8.09-8.01-7.72-7.41-7.38-7.41-8.26-8.84-9.18-9.67-9.54-9.76-10.41-9.33-8.07-7.02-5.53-4.99-4.51-3.72
Interest & Investment Income
0.33---0.15---------------
Other Non Operating Income (Expenses)
0.60.990.320.430.24-0.140.07-0.02-1.78-1.39-1.27-1.250.140.240.190.10.10-0.01-1.17
EBT Excluding Unusual Items
-27.74-32.32-35.16-39.33-40.88-39.93-42.45-43.41-44.1-46.97-52.1-59.35-62.05-61.56-58.39-55.21-56.2-54.09-43.84-35.32
Asset Writedown
-0.03-0.04-0.11-0.21-0.2-0.24-0.24-0.16-0.16-0.09-0.04-0.02-0.02-0.02-0.08-0.08-0.08-0.08--
Other Unusual Items
-0.4----0.25-0.25-0.25-0.25---3.98-4.03-6.98-6.98-3.10.072.390.680.91
Pretax Income
-27.76-31.96-35.27-39.54-41.08-40.42-42.93-43.82-44.51-47.06-52.15-63.35-66.1-68.56-65.45-58.39-56.21-51.78-43.16-34.41
Net Income
-27.76-31.96-35.27-39.54-41.08-40.42-42.93-43.82-44.51-47.06-52.15-63.35-66.1-68.56-65.45-58.39-56.21-51.78-43.16-34.41
Net Income to Common
-27.76-31.96-35.27-39.54-41.08-40.42-42.93-43.82-44.51-47.06-52.15-63.35-66.1-68.56-65.45-58.39-56.21-51.78-43.16-34.41
Net Income Growth (YoY)
--------------------
Shares Outstanding (Basic)
98877766544433222111
Shares Outstanding (Diluted)
98877766544433222111
Shares Change (YoY)
21.27%14.96%16.71%27.43%47.77%62.84%57.59%57.84%55.90%61.71%95.03%112.86%102.21%88.81%53.86%36.63%72.60%149.32%465.63%9281.60%
EPS (Basic)
-3.13-3.93-4.67-5.36-5.61-5.71-6.64-7.57-8.98-10.82-12.70-17.26-20.79-25.50-31.09-33.87-35.75-36.36-31.54-27.27
EPS (Diluted)
-3.13-3.93-4.67-5.36-5.61-5.71-6.64-7.57-8.98-10.83-12.70-17.26-20.79-25.50-31.09-33.87-35.75-36.36-31.54-27.27
EPS Growth (YoY)
--------------------

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
-20.24-25.1-23.53-29.16-31.13-45.01-51.88-62.21-60.99-45.97-45.79-44.4-45.83-50.27-48.27-45.12-42.77-32.03-30.46-28.96
Free Cash Flow Per Share
-2.28-3.08-3.12-3.95-4.25-6.36-8.02-10.74-12.30-10.57-11.15-12.10-14.41-18.70-22.93-26.17-27.20-22.49-22.27-22.95
Gross Margin
82.50%81.66%81.11%79.82%78.77%78.38%78.17%77.72%77.58%76.27%73.50%70.60%67.95%65.40%62.96%62.77%60.23%51.74%44.01%42.57%
Operating Margin
-19.99%-26.33%-31.37%-40.34%-44.27%-43.47%-48.03%-52.71%-54.42%-65.45%-84.13%-109.80%-124.35%-128.88%-132.17%-134.79%-162.47%-152.53%-72.14%-40.95%
Profit Margin
-26.97%-33.26%-39.85%-49.31%-53.66%-54.28%-60.19%-66.84%-73.08%-85.80%-106.23%-143.88%-158.72%-168.38%-171.27%-162.97%-179.84%-160.88%-79.18%-46.30%
Free Cash Flow Margin
-19.66%-26.12%-26.59%-36.37%-40.67%-60.45%-72.74%-94.89%-100.14%-83.82%-93.28%-100.85%-110.05%-123.45%-126.32%-125.93%-136.84%-99.52%-55.89%-38.96%
EBITDA
-15.01-19.67-22.1-26.61-28.08-26.58-28.49-29.26-28.55-31.94-37.97-45.09-48.42-49.01-46.91-44.74-47.32-45.76-36.14-27.38
EBITDA Margin
-14.58%-20.47%-24.97%-33.20%-36.67%-35.69%-39.94%-44.63%-46.88%-58.22%-77.35%-102.42%-116.28%-120.35%-122.76%-124.87%-151.39%-142.16%-66.31%-36.84%
D&A For EBITDA
5.585.635.675.735.825.795.775.34.593.963.333.253.363.473.63.553.463.343.183.05
EBIT
-20.58-25.3-27.77-32.35-33.89-32.37-34.26-34.56-33.14-35.9-41.3-48.34-51.78-52.48-50.51-48.3-50.78-49.1-39.32-30.43
EBIT Margin
-19.99%-26.33%-31.37%-40.34%-44.27%-43.47%-48.03%-52.71%-54.42%-65.45%-84.13%-109.80%-124.35%-128.88%-132.17%-134.79%-162.47%-152.53%-72.14%-40.95%
SEC Filings: 10-K · 10-Q